D-LUKAST L
USP/ Key features :
* Synergetic effect
* Montelukast : FDA approved for Chronic Asthma , Only Leukotriene antagonist approved to treat allergic Rhinitis ( GOLD STANDARD ANTI LEUKOTRIENE)
* LEVOCETIRIZINE : Long duration of action on improving total nasal symptoms score than fexofenadine , combination with montelukast ensure comparatively better quality of life , lesser side effect and low cost of therapy than fexofenadine
MOA :
* Levocetirizine-3rd Generation Non Sedative Antihistamine
* Montelukast –Leukotriene antagonist
Composition/Class : Levocetirizine 5mg + Montelukast Sodium 10mg
Indication : Seasonal allergic rhinitis/Hay Fever ,perennial allergic rhinitis,rhinitis associated with asthma , Idiopathic Urticaria